InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,264.33
(
-0.25%
)
US TECH 100
18,110.40
(
0.45%
)
Dow Jones
38,469.12
(
-0.56%
)
Brent Oil
78.68
(
-2.64%
)
Bitcoin
68,900.63
(
1.70%
)
Post# of 42563
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonDonDonDon

Send PM Follow Ignore
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

DonDonDonDon

Re: None

Tuesday, 06/14/2022 10:37:32 AM

Tuesday, June 14, 2022 10:37:32 AM

Post# of 42563
Lenzilumab stops Cytokine Release Syndrome dead in its tracks. Lenzilumab literally makes CAR-T a viable therapy.

https://www.fiercebiotech.com/biotech/asco-medidata-links-car-ts-cytokine-release-syndrome-risk-common-biomarkers-new-study

"Medidata found differences in common biomarkers such as platelet counts, serum albumin concentration, creatinine levels and neutrophil counts in patients who experienced severe CRS and those who did not.

CRS has led to the failure of at least 15 clinical trials since 2016, noted Medidata Vice President Jacob Aptekar, M.D"
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM

ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM

Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM

Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM

ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM

North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM

Start posting your company's news
Only $200 per official company press release!